Literature DB >> 17611350

Burkholderia cepacia complex: virulence characteristics, importance and relationship with cystic fibrosis.

Henrique Douglas Melo Coutinho1.   

Abstract

BACKGROUND: Burkholderia cepacia has been described as a cause of opportunist infections in patients with immune deficiency because of the high transmission rates. Actually the B. cepacia is subdivided in nine different genomic species that show morphological similarity, called genomovars. High mortality rates have been associated with infections caused by genomovars in susceptible patients; antibiotics are not efficient because of the high resistance level and genomic mutability. Little is known about the epidemiological traits of this bacterium; therefore, their isolation remains a relevant technical problem. AIMS: The objective of this review is to describe Burkholderia cepacia as a bacterial complex with high pathogenicity and variability of habitats.
MATERIALS AND METHODS: A systematic search was realized using the international bibliographic databanks SCIELO, HIGHWIRE, PUBMED, SCIRUS and LILACS to provide a useful and practical review for the health workers that do not know this microorganism.
CONCLUSIONS: Today, B. cepacia complex is a very important problem for the acquired immunodeficiency syndrome and cystic fibrosis patients. The immunodeficiency caused by these diseases is a positive factor for this microorganism to infect and kill these patients. Therefore, this opportunistic pathogen should be pointed out as a risk to these patients and hospitals all over the world must be prepared to detect and combat this bacterium.

Entities:  

Mesh:

Year:  2007        PMID: 17611350

Source DB:  PubMed          Journal:  Indian J Med Sci        ISSN: 0019-5359


  5 in total

1.  A rare case of community acquired Burkholderia cepacia infection presenting as pyopneumothorax in an immunocompetent individual.

Authors:  Suman S Karanth; Hariharan Regunath; Kiran Chawla; Mukhyaprana Prabhu
Journal:  Asian Pac J Trop Biomed       Date:  2012-02

2.  Ceftazidime-Resistant Burkholderia Cepacia: An Unusual Case in a Pregnant Patient.

Authors:  Rizwan Ishtiaq; Ali Akram; Laraib Zulfiqar; Daniyal Ishtiaq; Anam Ashraf; Mariam Arif
Journal:  Cureus       Date:  2017-11-01

3.  Antibacterial effects of microbial synthesized silver-copper nanoalloys on Escherichia coli, Burkholderia cepacia, Listeria monocytogenes and Brucella abortus.

Authors:  Sheida Mohammadi; Nima Hosseini Jazani; Mehri Kouhkan; Leila Ashrafi Babaganjeh
Journal:  Iran J Microbiol       Date:  2018-06

4.  Human Cryptic Host Defence Peptide GVF27 Exhibits Anti-Infective Properties against Biofilm Forming Members of the Burkholderia cepacia Complex.

Authors:  Andrea Bosso; Rosa Gaglione; Rocco Di Girolamo; Edwin J A Veldhuizen; Pilar García-Vello; Salvatore Fusco; Valeria Cafaro; Maria Monticelli; Rosanna Culurciello; Eugenio Notomista; Angela Arciello; Elio Pizzo
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-21

5.  Pulmonary bacterial pathogens in cystic fibrosis patients and antibiotic therapy: a tool for the health workers.

Authors:  Henrique Douglas M Coutinho; Vivyanne S Falcão-Silva; Gregório Fernandes Gonçalves
Journal:  Int Arch Med       Date:  2008-11-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.